ABOUT US

Embark Ventures is a pre-seed and seed stage fund focused on "deep tech" companies. We look for ambitious teams with break-through proprietary technology which provides a highly defensible competitive advantage in transforming multi-billion dollar industries.

Bio-Healthcare

Material Science

Software-Computing

Manufacturing-Industrial

Robotics-Automation

Sensors-Semiconductor

TEAM

Yipeng Zhao

Managing Partner

Peter Lee

Managing Partner

PORTFOLIO

K2 Cyber Security

Cloud workload security platform providing deterministic zero-day attack protection

Jiko

A personal private bank for everyone build on secure distributed computing infrastructure

InVia Robotics

Robotics-as-a-Service for warehouse automation providing immediate ROI and fast retrofit integration

Syntiant

Semi-conductor chip pushing cutting-edge machine learning from the cloud to edge devices

Truvian Health

Automated full blood panel testing platform in a self-serve kiosk

Avro Life Sciences

Advanced material patches for generic drug delivery through the skin

SeqOnce

Fast and simple library construction for Next Generation Sequencing

Kebotix

Revolutionize new materials discovery using AI and Robotics for rapid prototyping and closed loop feedback

SafeAI

Autonomous driving and safety platform for the heavy equipment industry in areas such as mining and construction

Via Separations

Molecular filtration for industrial processes using novel graphene membranes

Stealth

New quantum molecular simulation software founded by leading scientists

Stealth

Industrial robotic automation

Kula Bio

"Super-charge" natural nitrogen-fixing microbes with renewable energy to deliver reliable, low-cost organic biofertilizers.

CellFE

Microfluidics based device to deliver gene-editing molecules

Show More

NEWS

Truvian Health 12/20/2019

Truvian Health emerges from stealth to launch rapid blood testing device

Kebotix 12/03/2019

Kebotix, Koura Partner to Discover High-Performance Materials

Truvian Health 11/20/2019

Truvian Health raises $27M Series B for comprehensive blood testing device

inVia Robotics 11/07/2019

InVia Robotics highlighted on Fox news

Via Separations 10/2/2019

Chobani selects Via Separations for Food Tech Residency

Kebotix 09/24/2019

Kebotix Names Ashish Kulkarni as Independent Board Member

Show More

Embark Ventures, venture capital fund, venture capital, investors, Los Angeles, deep technology, frontier technology, technology investors, machine learning investor, cybersecurity investor, robotics investor, money, finance, investing, funding, project,